Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Basal-bolus or premixed? Shedding light on optimal insulin regime for type 1 diabetes.

Louise Walton E.

Biomed J. 2018 Dec;41(6):337-339. doi: 10.1016/j.bj.2018.12.008. Epub 2019 Jan 18.

3.

Responders to insulin therapy at 18 months in adults with newly diagnosed diabetes: which insulin regimen?

Idris I, Pillai A, Fernando DJ, Thomson G, Tate H.

Diabet Med. 2013 Mar;30(3):e95-100. doi: 10.1111/dme.12096.

PMID:
23215947
4.

Changes in insulin therapy regimens over 10 yr in children and adolescents with type 1 diabetes attending diabetes camps.

Redon I, Beltrand J, Martin D, Taupin P, Choleau C, Morandini M, Cahané M, Robert JJ; AJD health care teams.

Pediatr Diabetes. 2014 Aug;15(5):329-35. doi: 10.1111/pedi.12062. Epub 2013 Sep 9.

PMID:
24016246
5.

Premix insulins in type 1 diabetes: the coming of degludec/aspart.

Rendell M.

Expert Opin Drug Metab Toxicol. 2019 Apr;15(4):341-348. doi: 10.1080/17425255.2019.1585427. Epub 2019 Mar 18. Review.

PMID:
30789066
6.

New Insulins, Biosimilars, and Insulin Therapy.

Danne T, Heinemann L, Bolinder J.

Diabetes Technol Ther. 2018 Feb;20(S1):S55-S70. doi: 10.1089/dia.2018.2505. Review. No abstract available.

PMID:
29437477
7.

A prospective, longitudinal, multicenter, observational study to assess insulin treatment patterns in diabetic patients in Thailand: results from the TITAN Study.

Rawdaree P, Sarinnapakorn V, Pattanaungkul S, Khovidhunkit W, Tannirandorn P, Peerapatdit T.

J Med Assoc Thai. 2014 Nov;97(11):1140-50.

PMID:
25675678
8.

Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients.

Dunbar JM, Madden PM, Gleeson DT, Fiad TM, McKenna TJ.

Diabetes Care. 1994 Aug;17(8):874-8.

PMID:
7956634
9.

New Insulins, Biosimilars, and Insulin Therapy.

Danne T, Heinemann L, Bolinder J.

Diabetes Technol Ther. 2017 Feb;19(S1):S42-S58. doi: 10.1089/dia.2017.2505. Review. No abstract available.

PMID:
28192016
10.

Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus.

Garg S, Ampudia-Blasco FJ, Pfohl M.

Endocr Pract. 2010 May-Jun;16(3):486-505. doi: 10.4158/EP09294.RA. Review.

PMID:
20150026
11.

Insulin pumps improve glucose control in children with type 1 diabetes, study finds.

Mayor S.

BMJ. 2015 Nov 9;351:h5998. doi: 10.1136/bmj.h5998. No abstract available.

PMID:
26556780
12.
13.
14.

[Insulin treatment of adults with type 1 diabetes].

Pedersen-Bjergaard U, Thorsteinsson B.

Ugeskr Laeger. 2015 Sep 21;177(39):V04150330. Review. Danish.

PMID:
26418636
15.

Use of Insulin Pump in Neonates and Toddlers.

Klingensmith GJ.

Diabetes Technol Ther. 2015 Dec;17(12):857-9. doi: 10.1089/dia.2015.0339. No abstract available.

PMID:
26618720
16.

[Intensive insulin therapy in type 2 diabetes mellitus].

Jermendy G.

Orv Hetil. 2012 Sep 23;153(38):1487-93. doi: 10.1556/OH.2012.29451. Review. Hungarian.

PMID:
22985663
17.
18.

Safety and efficacy of insulin detemir basal-bolus therapy in type 1 diabetes patients: 14-week data from the European cohort of the PREDICTIVE study.

Dornhorst A, Lüddeke HJ, Honka M, Ackermann RW, Meriläinen M, Gallwitz B, Sreenan S; PREDICTIVE Study Group.

Curr Med Res Opin. 2008 Feb;24(2):369-76.

PMID:
18096110
19.

Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis.

Sharplin P, Gordon J, Peters JR, Tetlow AP, Longman AJ, McEwan P.

Cardiovasc Diabetol. 2009 Feb 16;8:9. doi: 10.1186/1475-2840-8-9.

20.

Premixed insulin regimens in type 2 diabetes: pros.

Maiorino MI, Bellastella G, Esposito K, Giugliano D.

Endocrine. 2017 Jan;55(1):45-50. doi: 10.1007/s12020-016-0917-6. Epub 2016 Mar 22.

PMID:
27003435

Supplemental Content

Support Center